Expert Opinion on the Therapeutic Use of the FixedRatio Combination of Insulin Glargine 100 U/mL and Lixisenatide: a Central/Eastern European Perspective
Pridané:
8.12.2020
Autori:
M. Haluzík, M. Flekač, C. Lengyel, Z. Taybani, C. Guja, B.M. Mihai, A. Cerghizan, E. Martinka, G Kovacs, P. Kempler, Diabetes Ther
https://doi.org/10.1007/s13300-020-00777-2, Received: December 23, 2019, The Author(s) 2020
